COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Pre-emptive Paracetamol for Prevention of Intraoperative Shoulder Tip Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04038307
Recruitment Status : Active, not recruiting
First Posted : July 30, 2019
Last Update Posted : January 27, 2020
Information provided by (Responsible Party):
Yasmin Hassab elnaby, Cairo University

Brief Summary:
the aim is to determine the efficacy of Paracetamol in reducing the incidence and severity of intraoperative shoulder pain in patients undergoing cesarean section.

Condition or disease Intervention/treatment Phase
Cesarean Section Drug: paracetamol Drug: Saline Solution Phase 2 Phase 3

Detailed Description:
pregnant females scheduled for cesarean section under spinal anesthesia will be enrolled . two groups of patents will be recruited . the study group will receive paracetamol pre operative .

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 120 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Pre-emptive Intravenous Paracetamol for Prevention of Intraoperative Shoulder Tip Pain in Patients Undergoing Caesarean Section: A Randomized Double Blind Controlled Clinical Trial.
Actual Study Start Date : August 1, 2019
Estimated Primary Completion Date : February 1, 2020
Estimated Study Completion Date : February 1, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cesarean Section

Arm Intervention/treatment
Placebo Comparator: control
will receive 100 ml of saline
Drug: Saline Solution

Experimental: paracetamol group
will receive 1gm paracetamol (100ml)
Drug: paracetamol

Primary Outcome Measures :
  1. incidence shoulder tip pain [ Time Frame: intraoperative ]
    presence of shoulder tip pain

Secondary Outcome Measures :
  1. numerical rating scale [ Time Frame: intraoperative ]
    severity of shoulder tip pain (0-10) where 0 is no pain and 10 is the worst pain ever

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Healthy pregnant women (ASA II) having singleton pregnancy at term (≤ 37 weeks of gestation) aged between 18 and 40 years.

Exclusion Criteria:

  • Patients having allergy to study drug,
  • gestational diabetes
  • cardiovascular or biliary disorders
  • asthma
  • renal impairment
  • preeclampsia
  • any chronic pain condition or trauma in the shoulder, forearms or upper limbs
  • patients with any contraindication to SA were excluded from the study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT04038307

Layout table for location information
Faculty of medicine
Cairo, Egypt
Sponsors and Collaborators
Cairo University
Layout table for additonal information
Responsible Party: Yasmin Hassab elnaby, principal investigator, Cairo University Identifier: NCT04038307    
Other Study ID Numbers: MS-12-2019
First Posted: July 30, 2019    Key Record Dates
Last Update Posted: January 27, 2020
Last Verified: January 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Yasmin Hassab elnaby, Cairo University:
shoulder tip pain
Additional relevant MeSH terms:
Layout table for MeSH terms
Analgesics, Non-Narcotic
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs